This cream helps psoriasis, but in a limited way. Moisturizing is a genuine part of psoriasis care, and this is the best base of any product here, with ceramides, niacinamide and urea in a rich, fragrance-free cream.
The active, salicylic acid 2%, is a real approved ingredient for psoriasis. It loosens and removes scale. That job matters, because scale acts as a barrier that can block a real treatment from reaching the skin.
What it does not do is treat the disease. Psoriasis is driven by an overactive immune process, and salicylic acid does not change that. It is best seen as an excellent moisturizer and scale remover, used alongside treatment, not instead of it.
| Key active | Salicylic acid 2% |
| Texture | Rich cream |
| Best for | Softening and removing psoriasis scale |
| Approximate price | $16–$20 |
| Fragrance | Fragrance free |
The base is the best of any psoriasis product here, and that is not faint praise — moisturizing is genuinely part of psoriasis care. Ceramides, niacinamide and urea, fragrance-free, in a rich cream that will properly hydrate a plaque.
Salicylic acid 2% is a real, monograph-approved active for psoriasis, and it does a real job: it loosens and removes scale.
And that job matters — because scale is a barrier. Stripping it is what allows a real treatment to actually reach the skin underneath.
Fragrance-free, and cheap.
Salicylic acid does not treat psoriasis. It descales it.
This is the most important thing on this page. Psoriasis is driven by an overactive immune process — specific inflammatory signals that make skin cells multiply far too fast. Salicylic acid does nothing to that process at all. It is a keratolytic: it dissolves the glue holding dead skin together, so the scale comes away.
It has no placebo-controlled evidence as a standalone psoriasis treatment. Its legitimate role is as an adjunct — clear the scale so that an actual drug can get in.
So this is fairly described as an excellent moisturizer with a descaler in it and a monograph claim on the box. It will make your plaques look better, feel better, and flake less. It is not treating your psoriasis.
Do not use salicylic acid over large areas of the body — it is absorbed, and at high total doses that becomes a genuine concern.
When to stop self-treating and see a doctor — this matters more than which cream you buy.
Psoriasis is not a skin problem. It is a systemic inflammatory disease.
Psoriatic arthritis develops in roughly 20–30% of people with psoriasis, and the joint damage it causes can be permanent if it is not treated. Psoriasis also carries a raised risk of cardiovascular disease, driven by long-term inflammation.
See a doctor if: You have any joint pain or stiffness — especially morning stiffness lasting over 30 minutes — or swollen fingers or toes Your plaques cover more than about 3–5% of your body (your palm is roughly 1%) It affects your face, scalp, genitals, palms, soles or nails It is not improving after a few weeks It is affecting your sleep or your mental health
Every one of these products says "ask a doctor if your condition does not improve." This is why.
Salicylic Acid 2%, Water, Urea, Glyceryl Stearate Se, Cetearyl Alcohol, Butyrospermum Parkii Butter, Glycerin, Niacinamide, Cetyl Alcohol, PEG-100 Stearate, Limnanthes Alba Seed Oil, Laureth-9, Gossypium Herbaceum Seed Oil, Behentrimonium Methosulfate, C12-13 Alkyl Lactate, 1,2-Hexanediol, Dimethicone, Ceramide NP, Ceramide AP, Ceramide EOP, Carbomer, Glyceryl Stearate, Sodium Hydroxide, Sodium Lauroyl Lactylate, Cholesterol, Tasmannia Lanceolata Fruit/Leaf Extract, Phenoxyethanol, Disodium EDTA, Tocopherol, Hydroxyacetophenone, Hydrogenated Olive Oil, Hydrolyzed Hyaluronic Acid, Citric Acid, Phytosphingosine, Xanthan Gum, Ethylhexylglycerin
1. FDA OTC Monograph M032: Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis for Over-the-Counter Human Use (https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M032-Drug%20Products%20for%20the%20Control%20of%20Dandruff%20Seborrheic%20Dermatitis%20and%20Psoriasis%2012.16.2021.pdf) — Confirms salicylic acid (1.8-3%) is a monograph-approved OTC active ingredient for psoriasis, supporting the claim that salicylic acid 2% is a 'real, monograph-approved active for psoriasis.' 2. Psoriasis: Update on Topical Therapy From the American Academy of Dermatology (https://www.aafp.org/pubs/afp/issues/2022/0500/p558.html) — AAD-based guidance stating salicylic acid reduces scaling and softens plaques, and that removing scale increases the penetration and effectiveness of other topical treatments — backing that descaling loosens/removes scale and lets real treatment reach the skin underneath. 3. Recommendations for adjunctive basic skin care in patients with psoriasis (https://pubmed.ncbi.nlm.nih.gov/24721699/) — Recommends emollients (including ceramides, urea, niacinamide, keratolytics) as adjunctive care that restores and protects skin barrier function, supporting that moisturizing is genuinely part of psoriasis care. 4. Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study (https://jcadonline.com/ceramide-july-2019/) — Studies CeraVe formulations containing ceramides, 2% salicylic acid, and urea in psoriasis patients, reporting improved skin appearance and relief — supporting the moisturizing base and keratolytic actives for plaques. 5. New insights of T cells in the pathogenesis of psoriasis (https://pmc.ncbi.nlm.nih.gov/articles/PMC4132586/) — Describes psoriasis as an immune-mediated disease driven by T cells that induce keratinocyte hyperproliferation, supporting the claim that psoriasis is immune-driven and that salicylic acid descales rather than treats the underlying disease. 6. Psoriasis Moisturizing Cream | CeraVe (https://www.cerave.com/skincare/moisturizers/psoriasis-moisturizing-cream) — Manufacturer page confirming the product's formulation: salicylic acid 2% active, three essential ceramides, niacinamide, and urea.